InvestorsHub Logo
Followers 7
Posts 96
Boards Moderated 0
Alias Born 09/03/2009

Re: biopharm post# 219543

Sunday, 05/17/2015 10:27:09 AM

Sunday, May 17, 2015 10:27:09 AM

Post# of 346002
Still believe the limited downside is worth risk for upside and no doubt the Entertainment value is increasing with share count imo. Can't make this stuff up and can't get that combo in too many places. Downside is only $1.37 x your share count & PPHM still squarely in Speculative bucket of investment, for me. Had to increment holding 50% since then to stay even on % target ownership - offset dilution. Done adding, for now. Will see it play out, even with inevitable share increase over next two years.

10Q says not to expect revenue for "at least two years". Some see that as forever, I see home stretch. Always advise using dog years when investing in Biotech. Approaching 3 for me and PPHM still acts like a pup.

My guess, bought out before final results, or realize the downside. Would prefer patients get cured over all options, so if BP better positioned to accelerate, good with that.

Good Luck
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News